NFKB1 and glioblastoma: On studying galectin-3 expression in glioblastoma cells exposed to a variety of stressing stimuli, Dumic and colleagues found that NF-κB inhibition by specific proteasomal inhibitors decreased the expression of galectin-3 (104).